David Seftel

David Seftel, MD, MBA, is a distinguished medical and business professional currently serving as the CEO, CFO, and CMO of Enable Biosciences since August 2015. Under David's leadership, the company has developed advanced COVID antibody testing and Type 1 diabetes diagnostic programs in collaboration with renowned institutions. David also holds numerous prominent roles, including President of Strategic Initiatives for the Harvard Business School Association of Northern California, Research Panel Reviewer for the National Institutes of Health, and Principal Investigator for several projects at the National Institute of Allergy and Infectious Diseases, National Science Foundation, and National Institute of Diabetes and Digestive and Kidney Diseases. Additional experience includes serving as Medical Director at Golden Gate Fields, contributing to innovative healthcare initiatives, and a long-term commitment to research in various medical fields, including allergy, diabetes, and macular degeneration. David's educational background includes an MBA from Harvard Business School and an MD from Witwatersrand University.